Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 175 of 215 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/26/20
End: 02/28/24
Due: 02/28/25
Phase: N/A
Priority: Normal
Start: 09/21/21
End: 09/23/21
Due: 09/23/22
Phase: N/A
Priority: Normal
Start: 10/31/10
End: 12/31/10
Due: 12/31/11
Phase: N/A
Priority: Normal
Start: 02/04/16
End: 06/07/19
Due: 06/07/20
Phase: N/A
Priority: Normal
Start: 08/07/24
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 06/30/08
Due: 06/30/09
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 06/30/06
End: 11/30/07
Due: 11/30/08
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 06/30/07
Due: 06/30/08
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 04/30/24
End: 02/24/25
Due: 02/24/26
Phase: N/A
Priority: Normal
Start: 05/17/13
End: 01/10/14
Due: 01/10/15
Phase: N/A
Priority: Normal
Start: 02/03/15
End: 04/01/15
Due: 04/01/16
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 02/28/14
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 09/24/20
End: 01/05/22
Due: 01/05/23
Phase: N/A
Priority: Normal
Start: 12/31/07
End: 06/30/08
Due: 06/30/09
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 07/31/17
Due: 07/31/18
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 04/30/08
Due: 04/30/09
Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 11/07/19
End: 02/17/20
Due: 02/17/21